Revenio’s Interim report for January- September 2026 to be published on November 12, 2026

Revenio will publish its Interim report January-September 2026 on Thursday, November 12, 2026 approximately at 09.00 a.m. (EET). The report will be available at www.reveniogroup.fi/en/ after the publication.

An audiocast and teleconference call for analysts and investors will be held in English at 3.00 p.m. (EET) on the same day.

The audiocast can be followed live at https://revenio.events.inderes.com/q3-2026

To ask questions, please join the teleconference by registering using the following link: https://events.inderes.com/revenio/q3-2026/dial-in

After registration, you will be provided with a phone number, user ID, and a conference ID to access the conference. To ask a question, please press #5 on your telephone keypad to enter the queue.

A recording of the audiocast will be published on www.reveniogroup.fi/en/ after the event.

For further information, please contact
CFO Jukka Kainulainen
+358 9 8775 1150
ir@revenio.fi

Distribution
Principal media
www.reveniogroup.fi/en 

Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix. 

In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. In 2025, the Group’s pro forma net sales totaled EUR 252.8 million, with a pro forma adjusted EBITDA of EUR 45.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.